 |
alfimeprase |
|---|---|
| Trade Name | |
| Orphan Indication | ST-elevation myocardial infarcted patients who are undergoing primary percutaneous coronary intervention |
| USA Market Approval | USA |
| USA Designation Date | 2012-09-20 00:00:00 |
| Sponsor | Niche Therapeutics, LLC;2009 Morton Avenue;Ann Arbor, Michigan, 48104 |
